The Polish government's economic committee recommended earlier this month that the full cabinet should free pharmaceutical prices in 1997, according to a report from Reuters. A government press statement said that for an intermediate period after freeing drug prices, the Finance Ministry would implement mechanisms which would prevent large, one-off jumps in drug prices.
The committee also stressed the need for quicker privatization of the Polish pharmaceutical industry, and said its production should be protected by duties on finished drug imports. In addition, it suggested that Poland should keep duty-free quotas for drug raw materials until 2000.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze